News Enbrel unlikely to face Novartis rival until 2018 Amgen arguing that US patent will last until 2029.
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Court bans US sales of Sanofi cholesterol drug Amgen looks to corner PCSK9 market after patent win.
News Novartis faces bribery probe in Greece Prosecutors raid Athens offices, according to press reports.
News US fines Teva $519m over foreign bribery charges Teva admits it bribed officials in Russia, Ukraine and Mexico.
News Ipsen licenses Simcere ADC in $1bn-plus deal Deal-hungry Ipsen is at it again, pledging around $1bn for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
